About Perrigo
Perrigo is a company based in Allegan (United States) founded in 1887.. The company has 8,380 employees as of December 31, 2024. Perrigo has completed 15 acquisitions, including Agisgroup, CanAm Care and Diba. Perrigo offers products and services including Ibuprofen Tablets, Infant Formula, Acetaminophen, and Minoxidil Topical Solution. Perrigo operates in a competitive market with competitors including Merck, AbbVie, Lilly, Roche and Novo Nordisk, among others.
- Headquarter Allegan, United States
- Employees 8380 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Perrigo Company Plc
-
Annual Revenue
$4.37 B-6.04as on Dec 31, 2024
-
Net Profit
$-171.8 M-1252.76as on Dec 31, 2024
-
EBITDA
$644 M0.36as on Dec 31, 2024
-
Latest Funding Round
$600 M (USD), Post-IPO
Sep 11, 2016
-
Investors
-
Employee Count
8380
as on Dec 31, 2024
-
Investments & Acquisitions
Agisgroup
& 14 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Perrigo
Perrigo is a publicly listed company on the NYSE with ticker symbol PRGO in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Perrigo
Perrigo offers a comprehensive portfolio of products and services, including Ibuprofen Tablets, Infant Formula, Acetaminophen, and Minoxidil Topical Solution. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Tablets for reducing pain and fever in consumers
Formula for infant feeding and nutrition support
Medication for pain and fever management
Treatment for hair regrowth in men
Unlock access to complete
Unlock access to complete
Software Development Team
141 people
Leadership Team
90 people
Sales and Marketing
74 people
Senior Team
49 people
Operations Team
32 people
Human Resources and Administration
23 people
Global Team
23 people
Finance and Accounting
21 people
Unlock access to complete
Funding Insights of Perrigo
- Total Funding Total Funding
- Total Rounds 1
- Last Round Post-IPO — $600.0M
-
First Round
First Round
(11 Sep 2016)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2016 | Amount | Post-IPO - Perrigo | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Perrigo
Perrigo has strategically engaged in corporate development activities, having acquired 15 companies. Notable acquisitions include Agisgroup, CanAm Care and Diba. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Gelcaps are exported from Mexico by the company since 2018.
|
2018 | ||||
|
Agisgroup was founded in 2010 with domain agisgroup.com.
|
2010 | ||||
|
Manufacturer of pharmaceutical eye drop product
|
2009 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Perrigo
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Perrigo Comparisons
Competitors of Perrigo
Perrigo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, AbbVie, Lilly, Roche and Novo Nordisk, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| domain | founded_year | HQ Location |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| domain | founded_year | HQ Location |
Pharmaceuticals and diagnostics kits are developed for various diseases.
|
|
| domain | founded_year | HQ Location |
Drugs for diabetes, obesity, hemophilia, and hormone therapy are manufactured.
|
|
| domain | founded_year | HQ Location |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Perrigo
Frequently Asked Questions about Perrigo
When was Perrigo founded?
Perrigo was founded in 1887 and raised its 1st funding round 129 years after it was founded.
Where is Perrigo located?
Perrigo is headquartered in Allegan, United States. It is registered at Allegan, Michigan, United States.
Who is the current CEO of Perrigo?
Patrick Lockwood Taylor is the current CEO of Perrigo.
How many employees does Perrigo have?
As of Dec 31, 2024, the latest employee count at Perrigo is 8,380.
What is the annual revenue of Perrigo?
Annual revenue of Perrigo is $4.37B as on Dec 31, 2024.
What does Perrigo do?
Perrigo was founded in 1887 and is headquartered in Allegan, United States. Over-the-counter and generic prescription pharmaceuticals, infant formulas, nutritional products, dietary supplements, and active pharmaceutical ingredients are produced and distributed by the company within the healthcare sector. Operations focus on consumer goods, with royalties earned from Tysabri, a treatment for multiple sclerosis and Crohns disease.
Who are the top competitors of Perrigo?
Perrigo's top competitors include Merck, Roivant Sciences and Amgen.
What products or services does Perrigo offer?
Perrigo offers Ibuprofen Tablets, Infant Formula, Acetaminophen, and Minoxidil Topical Solution.
Is Perrigo publicly traded?
Yes, Perrigo is publicly traded on NYSE under the ticker symbol PRGO.
How many acquisitions has Perrigo made?
Perrigo has made 15 acquisitions, including Agisgroup, CanAm Care, and Diba.
What is Perrigo's ticker symbol?
The ticker symbol of Perrigo is PRGO on NYSE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.